Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
Clinical trial NCT05349214 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05349214
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-04
- Primary completion
- 2025-05-13
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.